{"url_path":"/sec/tara/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1359931/0001213900-26-055463-index.html","accession_number":"0001213900-26-055463","cik":"0001359931","ticker":"TARA","issuer_name":"Protara Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1359931/0001213900-26-055463-index.html","primary_entity_key":"0001359931","primary_entity_name":"Protara Therapeutics, Inc."},"word_count":239,"has_tables":true,"body_markdown":"**Item 5. Other Information**\n\n  \n\nThe following table provides\ninformation concerning Rule 10b5-1 trading arrangements (as defined in Item 408 of Regulation S-K under the Exchange Act) adopted, modified,\nor terminated in the three months ended March 31, 2026 by any director or any executive officer who is subject to the filing requirements\nof Section 16 of the Exchange Act. These trading arrangements are intended to satisfy the affirmative defense of Rule 10b5-1(c). These\ntrading arrangements permit transactions through and including the earlier to occur of (a) the completion of all purchases or sales or\n(b) the date listed in the table below. These trading arrangements, identified as “Rule 10b5-1 Trading Arrangements”, only\npermit transactions upon expiration of the applicable mandatory cooling-off period under Rule 10b5-1.\n\n \n\n**Name (Title)**   **Action Taken (Date of Action)**   **Nature of Trading Arrangement**   **Type of\nTrading Arrangement**   **Duration of\nTrading Arrangement**   **Aggregate Number of Securities**  \n\nJesse Shefferman *(President, Chief Executive Officer and Director)*   Termination\n(March 17, 2026)   Sale   Rule 10b5-1 trading arrangement   March 25, 2026 – September 24, 2026     69,448  \n\nJesse Shefferman *(President, Chief Executive Officer and Director)*   Adoption\n(March 17, 2026)   Sale   Rule 10b5-1 trading arrangement   June 16, 2026 – April 28, 2028     754,054  \n\n \n\nNo other director or officer of the Company adopted\nor terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined\nin Item 408(a) of Regulation S-K, during the three months ended March 31, 2026.\n\n \n\n26"}